These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23467020)

  • 1. Three- and four-body corrected fragment molecular orbital calculations with a novel subdividing fragmentation method applicable to structure-based drug design.
    Watanabe C; Fukuzawa K; Okiyama Y; Tsukamoto T; Kato A; Tanaka S; Mochizuki Y; Nakano T
    J Mol Graph Model; 2013 Apr; 41():31-42. PubMed ID: 23467020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular interactions between estrogen receptor and its ligand studied by the ab initio fragment molecular orbital method.
    Fukuzawa K; Mochizuki Y; Tanaka S; Kitaura K; Nakano T
    J Phys Chem B; 2006 Aug; 110(32):16102-10. PubMed ID: 16898767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ab initio quantum mechanical study of the binding energies of human estrogen receptor alpha with its ligands: an application of fragment molecular orbital method.
    Fukuzawa K; Kitaura K; Uebayasi M; Nakata K; Kaminuma T; Nakano T
    J Comput Chem; 2005 Jan; 26(1):1-10. PubMed ID: 15521089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of CH/π hydrogen bonds in recognition of the core motif in proline-recognition domains: an ab initio fragment molecular orbital study.
    Ozawa T; Okazaki K; Kitaura K
    J Comput Chem; 2011 Oct; 32(13):2774-82. PubMed ID: 21710635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
    J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential recognition of resveratrol isomers by the human estrogen receptor-alpha: molecular dynamics evidence for stereoselective ligand binding.
    Abou-Zeid LA; El-Mowafy AM
    Chirality; 2004 Mar; 16(3):190-5. PubMed ID: 14770416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of probable mutations in influenza virus hemagglutinin protein based on large-scale ab initio fragment molecular orbital calculations.
    Yoshioka A; Fukuzawa K; Mochizuki Y; Yamashita K; Nakano T; Okiyama Y; Nobusawa E; Nakajima K; Tanaka S
    J Mol Graph Model; 2011 Sep; 30():110-9. PubMed ID: 21798776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the molecular basis of action of ring D aromatic steroidal antiestrogens.
    Alvarez LD; Veleiro AS; Burton G
    Proteins; 2015 Jul; 83(7):1297-306. PubMed ID: 25921217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VISCANA: visualized cluster analysis of protein-ligand interaction based on the ab initio fragment molecular orbital method for virtual ligand screening.
    Amari S; Aizawa M; Zhang J; Fukuzawa K; Mochizuki Y; Iwasawa Y; Nakata K; Chuman H; Nakano T
    J Chem Inf Model; 2006; 46(1):221-30. PubMed ID: 16426058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA and estrogen receptor interaction revealed by fragment molecular orbital calculations.
    Watanabe T; Inadomi Y; Fukuzawa K; Nakano T; Tanaka S; Nilsson L; Nagashima U
    J Phys Chem B; 2007 Aug; 111(32):9621-7. PubMed ID: 17649990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization analysis of inter-fragment interaction energies of CRP-cAMP-DNA complex based on the fragment molecular orbital method.
    Kurisaki I; Fukuzawa K; Komeiji Y; Mochizuki Y; Nakano T; Imada J; Chmielewski A; Rothstein SM; Watanabe H; Tanaka S
    Biophys Chem; 2007 Oct; 130(1-2):1-9. PubMed ID: 17656003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FMOe: Preprocessing and Visualizing Package of the Fragment Molecular Orbital Method for Molecular Operating Environment and Its Applications in Covalent Ligand and Metalloprotein Analyses.
    Moriwaki H; Kawashima Y; Watanabe C; Kamisaka K; Okiyama Y; Fukuzawa K; Honma T
    J Chem Inf Model; 2024 Sep; 64(18):6927-6937. PubMed ID: 39235048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular recognition in nicotinic acetylcholine receptors: the importance of pi-cation interactions.
    Schmitt JD; Sharples CG; Caldwell WS
    J Med Chem; 1999 Aug; 42(16):3066-74. PubMed ID: 10447950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charge clamps of lysines and hydrogen bonds play key roles in the mechanism to fix helix 12 in the agonist and antagonist positions of estrogen receptor α: intramolecular interactions studied by the ab initio fragment molecular orbital method.
    Watanabe C; Fukuzawa K; Tanaka S; Aida-Hyugaji S
    J Phys Chem B; 2014 May; 118(19):4993-5008. PubMed ID: 24725156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular simulation of interaction between estrogen receptor and selective estrogen receptor modulators.
    Guo ZR; Yi X; Xu ZB
    Acta Pharmacol Sin; 2002 Mar; 23(3):208-12. PubMed ID: 11918843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-Protein Interaction Modelling with the Fragment Molecular Orbital Method.
    Tanaka S
    Methods Mol Biol; 2023; 2552():295-305. PubMed ID: 36346599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDS: flexible ligand and receptor docking with a continuum solvent model and soft-core energy function.
    Taylor RD; Jewsbury PJ; Essex JW
    J Comput Chem; 2003 Oct; 24(13):1637-56. PubMed ID: 12926007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site.
    Anstead GM; Carlson KE; Katzenellenbogen JA
    Steroids; 1997 Mar; 62(3):268-303. PubMed ID: 9071738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design.
    Zhou Z; Bates M; Madura JD
    Proteins; 2006 Nov; 65(3):580-92. PubMed ID: 16972282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of protein-ligand binding site polarizability.
    Nayeem A; Krystek S; Stouch T
    Biopolymers; 2003 Oct; 70(2):201-11. PubMed ID: 14517908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.